In vivo tumor growth inhibition by novel PKM2 cancer metabolism modulators.

瓦博格效应 巴基斯坦卢比 体内 癌症研究 癌细胞 变构调节 细胞生长 厌氧糖酵解 癌症 丙酮酸激酶 细胞培养 糖酵解 生物化学 医学 生物 化学 酶 内科学 生物技术 遗传学
作者
Oren M. Becker,Vered Behar,Osnat Bohana‐Kashtan,Alina Shitrit,Daniel A. Sherman,Efrat Ben‐Zeev,Rachel Ozeri,Nili C. Schutz,Avihai Yacovan
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:29 (15_suppl): 10530-10530 被引量:1
标识
DOI:10.1200/jco.2011.29.15_suppl.10530
摘要

10530 Background: Cancer cells undergo major metabolic changes to enable efficient conversion of glucose needed for cell growth and proliferation. This phenomenon, which takes place even when oxygen is abundant, is known as the Warburg effect. A key mediator of this effect is pyruvate kinase (PK), a rate-limiting enzyme that catalyzes the last step in glycolysis. PK subtype M2 (PKM2), which is over expressed in cancer cells, facilitates the Warburg effect by switching from a highly active tetrameric form to low activity monomeric or dimeric forms. Thus small molecule PKM2 activators that stabilize the tetrameric form are expected to renormalize cancer metabolism, offering a novel therapeutic strategy. Methods: Novel PKM2 activators were discovered using a structure-based approach, and tested in multiple in vitro and in vivo studies. Results: Several series of novel, potent, allosteric PKM2 activators with AC50s as low as 20nM were discovered. By stabilizing the active tetrameric form of PKM2 more than 10-fold, these activators lower the levels of lactate in cancer cells, thus countering the Warburg effect. In cellular assays, these compounds significantly reduce the proliferation rate of multiple cancer cell lines, representing 5 different tumor types (colorectal, renal, lung, cervix, liver). So far, the greatest sensitivity was observed in colorectal cancer (CRC) and renal cell carcinoma (RCC) cell lines. Combination with commonly used chemotherapeutic agents show an additive, and in some cases a slight synergistic, effect on cells. In in vivo mouse xenograft models with the CRC cell line HT29, even a modestly active compound, such as DNX-03013 (AC50=0.9uM), demonstrated within a few days of treatment tumor growth inhibition greater than 50% (200 and 400 mg/kg IP QD). The compound was safe in mouse even at high exposure levels (400 mg/kg IP QD), indicating that these efficacious doses are significantly below the MTD. Conclusions: Taken together, this is the first report of potent PKM2 novel small-molecule cancer metabolism modulators that show promising anti-cancer therapeutic potential in vivo. The favorable DMPK profile of these compounds suggests that they can be further developed either as mono-therapy or as combination therapy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
syvshc的应助被米兔采纳,获得10
刚刚
科目三的应助被lin采纳,获得10
1秒前
小二郎的应助被zzk采纳,获得10
1秒前
秋风的应助被Tang采纳,获得20
2秒前
2秒前
盒子发布了新的文献求助30
3秒前
科研通AI2S的应助被爱笑的阿满采纳,获得10
4秒前
4秒前
5秒前
6秒前
Ginge完成签到,获得积分10
7秒前
失约于月光完成签到,获得积分10
7秒前
风吹麦浪的应助被牧百川采纳,获得10
7秒前
荣离枯发布了新的文献求助10
8秒前
8秒前
8秒前
九亿少男的噩梦完成签到 ,获得积分20
8秒前
8秒前
8秒前
8秒前
哈哈发布了新的文献求助10
9秒前
抹茶肥肠完成签到,获得积分10
9秒前
10秒前
Komorebi发布了新的文献求助10
10秒前
10秒前
可笑可笑完成签到,获得积分10
11秒前
12秒前
希望天下0贩的0的应助被fiveaa采纳,获得10
12秒前
12秒前
13秒前
hebo完成签到,获得积分10
13秒前
WZM发布了新的文献求助10
13秒前
研友_nPPERn发布了新的文献求助10
13秒前
扶摇发布了新的文献求助10
14秒前
14秒前
14秒前
14秒前
15秒前
枫树狐狸发布了新的文献求助10
15秒前
lin发布了新的文献求助10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183298
求助须知:如何正确求助?哪些是违规求助? 9572606
关于积分的说明 21826444
捐赠科研通 7780272
什么是DOI,文献DOI怎么找? 3433993
关于科研通互助平台的介绍 2558136
邀请新用户注册赠送积分活动 2480259